Research Article

Related GMR Articles

08/28/2014
Apoptosis; Follicular atresia; Fox O1

Follicular atresia, a key phenomenon in follicle development, eliminates most of the follicles in mammalian ovaries. To investigate the molecular mechanism of follicular atresia in porcine ovaries, we investigated the mRNA expression of three important cell death ligand-receptor systems and Fox O1 in follicles with a diameter of 3-5 mm. The phosphorylation and subcellular localization of ... more

F. Lin; Y.H. Fu; J. Han; M. Shen; C.W. Du; R. Li; X.S. Ma; H.L. Liu
08/25/2014
Apoptosis; Apoptotic genes; Icariin; Nephrectomy

The aim of this study was to investigate the renal protective effect of icariin in 5/6 nephrectomized rats and the molecular mechanisms involved. Forty male Sprague-Dawley rats were randomly divided into 5 groups: sham-operated group, 5/6 nephrectomy model group, icariin groups (20 and 40 mg/kg), and benazepril group. After 12-weeks treatment, 24-h urine and serum were collected, and ... more

S.R. Liang; J.W. Bi; Z.L. Guo; Y. Bai; Z. Hu
08/17/2010
Bladder cancer; Gene polymorphism; Meta-analysis; p53 codon 72

Although there have been many studies investigating a possible association between p53 codon 72 polymorphism and risk of bladder cancer, the results have been inconsistent. We conducted a meta-analysis of six epidemiological studies, which included 597 bladder cancer cases and 731 controls. Patients with bladder cancer had a significantly lower frequency of Pro/Arg [odds ratio (OR) = 0.80 ... more

D.B. Li; X. Wei; L.H. Jiang; Y. Wang; F. Xu
04/13/2010
Bladder cancer; CCR2-V64I; Chemokines; MCP-1 A-2518G; Polymorphism

Chemokines are potent proinflammatory cytokines that are implicated in numerous inflammatory diseases. Proinflammatory gene polymorphisms lead to variations in the production and concentration of inflammatory proteins. We investigated a possible association between polymorphisms in chemokine and chemokine receptor genes (MCP-1 A-2518G and CCR2-V64I) and bladder cancer risk. Genotypes were ... more

K.F. Narter; B. Agachan; S. Sozen; Z.B. Cincin; T. Isbir
05/06/2013
Bladder cancer; KEGG pathway; T1-T2; Ta-T1; Tumor grades

Bladder cancer is a highly heterogeneous neoplasm. We examined the gene expression profile in 3 bladder cancer stages (Ta, T1, T2) using expression microarray analysis of 40 bladder tumors. Differentially expressed genes were found by the t-test, with <0.005 as the significance threshold. KEGG pathway-enrichment analysis was used to study the signaling pathways of the genes. ... more

Z.Q. Fang; W.D. Zang; R. Chen; B.W. Ye; X.W. Wang; S.H. Yi; W. Chen; F. He; G. Ye
04/02/2013
Bladder cancer; Recurrence; Survivin; Vascular endothelial growth factor

Survivin and vascular endothelial growth factor (VEGF) are newly discovered tumor markers closely correlated with bladder cancer. We analyzed the expression of survivin and VEGF in paraffin-embedded tumor tissues from 78 patients with bladder transitional cell carcinoma (BTCC) using an immunohistochemistry method. Normal bladder mucosae from 10 non-BTCC cases were also included as a ... more

Y.W. Sun; Q. Xuan; Q.A. Shu; S.S. Wu; H. Chen; J. Xiao; P. Xiang; Y.P. Zhu; F.L. Wang; S.T. Zhao
09/26/2012
Bladder cancer; Genetic susceptibility; hOGG1; Meta-analysis; Polymorphism

The functional polymorphism Ser326Cys (rs1052133) in the human 8-oxoguanine DNA glycosylase (hOGG1) gene has been implicated in bladder cancer risk. However, reports of this association between the Ser326Cys polymorphism and bladder cancer risk are conflicting. In order to help clarify this relationship, we made a meta-analysis of seven case-control studies, summing 2521 cases ... more

D.Y. Zhong; H.Y. Chu; M.L. Wang; L. Ma; D.N. Shi; Z.D. Zhang
11/28/2014
Bladder cancer; Gene polymorphism; Meta-analysis; XRCC1 Arg399Gln

We examined whether the X-ray repair cross-complementing group 1 (XRCC1) Arg399Gln polymorphism is a risk factor for bladder cancer by conducting a meta-analysis. We searched the Pubmed and Embase databases for study retrieval. This meta-analysis examined 16 case-control studies, including 892 prostate cancer cases and 1020 healthy controls. Meta-analysis results based on these studies ... more

L.M. Dong; X.Y. Zhang; H. Teng; M.S. Li; P. Wang
07/25/2014
Bladder cancer; Meta-analysis; PSCA; rs2294008 (C>T) polymorphism

Several published articles have evaluated the association between the prostate stem cell antigen (PSCA) rs2294008 (C>T) polymorphism and bladder cancer risk, but the results remain inconclusive. In order to derive a more precise estimation of the association, we performed a meta-analysis of four case-control studies that included 9617 cases and 16,323 controls. Odds ratios (ORs) and 95 ... more

Y. Zhao; Z.L. Gui; S. Liao; F. Gao; Y.Z. Ge; R.P. Jia
04/30/2014
Bladder cancer; Control mechanism; Genes; Module network

Bladder cancer is a common cancer worldwide and its incidence continues to increase. There are approximately 261,000 cases of bladder cancer resulting in 115,000 deaths annually. This study aimed to integrate bladder cancer genome copy number variation information and bladder cancer gene transcription level expression data to construct a causal-target module network of the range of ... more

J.M. Wang; Y.Q. Wang; Z.L. Gao; J.T. Wu; B.K. Shi; C.C. Yu

Pages